K. Kaji

Identification of a novel autoantibody reactive with 155 and 140 kDa nuclear proteins in patients with dermatomyositis: an association with malignancy

K. Kaji, Manabu Fujimoto, Minoru Hasegawa et al. · Lara D. Veeken · 2006 · 304 citations · Full text

Life Sciences, Immunology, Pathology +17

Autoantibodies to RuvBL1 and RuvBL2: A Novel Systemic Sclerosis–Related Antibody Associated With Diffuse Cutaneous and Skeletal Muscle Involvement

K. Kaji, Noreen Fertig, Thomas A. Medsger et al. · Arthritis Care & Research · 2013 · 117 citations

Life Sciences, Clinical Sciences, Immunology +17

The clinical relevance of serum antinuclear antibodies in Japanese patients with systemic sclerosis

Yasuhito Hamaguchi, Minoru Hasegawa, Manabu Fujimoto et al. · British Journal of Dermatology · 2008 · 115 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +17

Association of distinct clinical subsets with myositis‐specific autoantibodies towards anti‐155/140‐kDa polypeptides, anti‐140‐kDa polypeptides, and anti‐aminoacyl tRNA synthetases in Japanese patients with dermatomyositis: a single‐centre, cross‐sectional study

Keita Fujikawa, Atsushi Kawakami, K. Kaji et al. · Scandinavian Journal of Rheumatology · 2009 · 88 citations

Life Sciences, Immunology, Pathology +17

Reduced red blood cell velocity in nail-fold capillaries as a sensitive and specific indicator of microcirculation injury in systemic sclerosis

Naoki Mugii, Minoru Hasegawa, Y. Hamaguchi et al. · Lara D. Veeken · 2009 · 59 citations · Full text

Medicine, Clinical Sciences, Pathology +12